CRINETICS PHARMACEUTICALS INC stock forecast: up to 46.39 USD CRNX stock price prognosis

STOCK

Forecast for Thu 27 Jun 2024 price 47.79

CRINETICS PHARMACEUTICALS INC stock price forecast for further price development up to 7.57% (time horizon: 1 day) and price target of 46.39 USD. Short-term (time horizon: 2 weeks) CRINETICS PHARMACEUTICALS INC share price prediction for 2024-06-27 with daily closed price projections

Key Facts

Symbol CRNX 

ISIN US22663K1079 

CUSIP 22663K107


Currency USD


Category Pharmaceutical Preparations

Forecast price change %

Relative Strength Index (RSI)

Finance numbers

Revenue 0.0


Earnings per share -2.40


On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

NETs originate from neuroendocrine cells commonly found in the gut, lung or pancreas. A new tablet formulation of paltusotine is planned for use in both trials. This decline reached steady state in approximately seven days. Further, glucagon secretion was not suppressed in these experiments. Rescue of glyburide-induced hypoglycemia by CRN04777 in rats. If surgery is not an option, medical therapy may be used to block cortisol production. We own issued patents and patent applications relating to our product candidates. For these reasons, we may face competition with respect to our product candidates. The FDA will not approve the NDA without an approved REMS, if required. 2, San Diego, California 92121, and our telephone number is (858) 450-6464. The development of biopharmaceutical product candidates is capital-intensive. In addition, our product candidates, if approved, may not achieve commercial success. In either case, our development costs would increase. Obtaining and maintaining reimbursement status is time-consuming, costly and uncertain. In particular, there is intense competition in the field of endocrine disorders. Further, new studies may change the estimated incidence or prevalence of these diseases. The CCPA may increase our compliance costs and potential liability. Further, the California Privacy Rights Act, or CPRA, recently passed in California. Accordingly, the market price of shares of our common stock may decline. Litigation may be necessary to defend against these claims. Item 1B. Unresolved Staff Comments None.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1658247/000156459021016719/0001564590-21-016719.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 39.06/100
    • Good financial position.
    • Historical view, profit is growing.
    • Company revenue is not growing faster compared with the industry.

Institutional ownership list is based on filling form information

Holding name Date Amount
A - BARCLAYS PLC 2023-06-30 92093
A - OSAIC HOLDINGS, INC. 2023-06-30 2412
China Universal Asset Management Co., Ltd. 2023-06-30 708
VOYA INVESTMENT MANAGEMENT LLC 2022-09-30 20606
MetLife Investment Management, LLC 2022-12-31 28047

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Pacer Funds Trust 2023-07-31 1038 Long
Prudential Sector Funds, Inc. 2023-11-30 674789 Long
Tema ETF Trust 2023-11-30 10387 Long
Prudential Jennison Blend Fund, Inc. 2023-11-30 41634 Long
BNY Mellon ETF Trust 2023-11-30 4507 Long

Insider trading for CRINETICS PHARMACEUTICALS INC

CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1742616 Okey Stephanie 2024-03-28 SALE Accept Accept Accept Accept
1702265 Wilson Marc 2024-03-19 SALE Accept Accept Accept Accept
1886575 Betz Stephen F. 2024-01-25 SALE Reject Reject Accept Reject
1746298 Struthers Richard Scott 2024-04-04 SALE Reject Reject Reject Reject
1397266 Fust Matthew K 2024-03-20 SALE Accept Accept Accept Accept
1435775 Krasner Alan Seth 2023-10-17 SALE Accept Accept Accept Accept
1948238 Pizzuti Dana 2024-03-20 SALE Accept Accept Accept Accept
1881007 Knight Jeff E. 2024-03-22 SALE Accept Accept Accept 0


Bollinger Bollinger Bands for CRINETICS PHARMACEUTICALS INC can provide the information where the market is moving based on price information.


CRINETICS PHARMACEUTICALS INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.



Converting prices to returns CRINETICS PHARMACEUTICALS INC.


On-Balance Volume information for CRINETICS PHARMACEUTICALS INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.



Accumulation / Distribution (A/D) indicator information for CRINETICS PHARMACEUTICALS INC. The indicator identify divergences between price and volume flow.


Aroon Oscillator information for CRINETICS PHARMACEUTICALS INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.


Average Directional Index (ADX) information for CRINETICS PHARMACEUTICALS INC. The index can be used to identify the strengh of a trend.


Moving Average Convergence Divergence (MACD) for CRINETICS PHARMACEUTICALS INC. The indicator helps to predict trend direction and the momentum of the trend.


Stochastic Oscillator as momentum indicator for CRINETICS PHARMACEUTICALS INC. The indicator is useful for identifying overbought and oversold levels.


Relative Strength Index (RSI) for CRINETICS PHARMACEUTICALS INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].


Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.


The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.


The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.


Moving Average Crossover


52W High 52W Low Market Cap

Similar shares


CRINETICS PHARMACEUTICALS INC on Nasdaq

CRINETICS PHARMACEUTICALS INC on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2024-05-24 46.39 2024-05-02 09:44
2024-05-22 46.35 2024-05-02 09:44
2024-05-23 46.17 2024-05-02 09:44
2024-05-20 46.16 2024-05-02 09:44
2024-05-21 46.15 2024-05-02 09:44
2024-06-07 46.77 2024-05-02 09:44
2024-05-30 46.45 2024-05-02 09:44
2024-06-05 46.61 2024-05-02 09:44
2024-05-29 46.23 2024-05-02 09:44
2024-06-03 46.54 2024-05-02 09:44
2024-06-04 46.48 2024-05-02 09:44
2024-05-31 46.39 2024-05-02 09:44
2024-05-27 46.12 2024-05-02 09:44
2024-05-28 46.35 2024-05-02 09:44
2024-06-10 46.79 2024-05-02 09:44
2024-06-11 46.93 2024-05-02 09:44
2024-06-06 46.63 2024-05-02 09:44
2024-06-12 46.93 2024-05-02 09:44
2024-06-19 47.36 2024-05-02 09:44
2024-06-17 47.19 2024-05-02 09:44
2024-06-18 47.21 2024-05-02 09:44
2024-06-13 47.05 2024-05-02 09:44
2024-06-14 47.05 2024-05-02 09:44
2024-06-20 47.38 2024-05-02 09:44
2024-06-24 47.53 2024-05-02 09:44
2024-06-25 47.64 2024-05-02 09:44
2024-06-21 47.51 2024-05-02 09:44
2024-06-26 47.68 2024-05-02 09:44
2024-05-13 45.81 2024-05-02 09:44
2024-05-14 45.99 2024-05-02 09:44
2024-06-27 47.79 2024-05-02 09:44
2024-05-15 45.73 2024-05-02 09:44
2024-05-16 45.86 2024-05-02 09:44
2024-05-06 45.03 2024-05-02 09:44
2024-05-07 44.84 2024-05-02 09:44
2024-05-08 45.46 2024-05-02 09:44
2024-05-09 45.20 2024-05-02 09:44
2024-05-17 45.85 2024-05-02 09:44
2024-05-10 45.65 2024-05-02 09:44

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.